AA
KRRO icon

ALPS Advisors’s Korro Bio KRRO Stock Holding History

ALPS Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-844
Closed -$298K – 935
2021
Q3 		$298K Sell
844
-57
-6% -$22.4K ﹤0.01% 862
2021
Q2 		$449K Sell
901
-320
-26% -$156K ﹤0.01% 537
2021
Q1 		$580K Buy
1,221
+5
+0.4% +$9.71K 0.01% 481
2020
Q4 		$2.14M Buy
1,216
+358
+42% +$473K 0.02% 258
2020
Q3 		$824K Buy
858
+12
+1% +$12.9K 0.01% 368
2020
Q2 		$984K Sell
846
-273
-24% -$247K 0.01% 315
2020
Q1 		$997K Sell
1,119
-131
-10% -$141K 0.02% 273
2019
Q4 		$1.1M Buy
+1,250
New +$972K 0.01% 328

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ALPS Advisors's KRRO Position: Q4 2021 in Review

ALPS Advisors sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 844 shares — an estimated $298K sold.

ALPS Advisors first reported a position in KRRO in Q4 2019 and held it in 8 quarters. The position peaked at $2.14M in Q4 2020. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

  • ALPS Advisors reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 844 Korro Bio shares in Q4 2021, an estimated $298K.
  • ALPS Advisors first reported a position in Korro Bio in Q4 2019 and held it in 8 quarters.
  • ALPS Advisors's Korro Bio position peaked at $2.14M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.